Kearns Evan 4
4 · Cogent Biosciences, Inc. · Filed Jan 25, 2024
Insider Transaction Report
Form 4
Kearns Evan
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-23+255,000→ 255,000 totalExercise: $4.63Exp: 2034-01-23→ Common Stock (255,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.